Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Hormonal receptor expression in endometrial carcinoma: a retrospective immunohistochemical study in a Nigerian tertiary hospital

Background: Endometrial carcinoma is the commonest genital tract malignancy in most developed nations, but it lags behind cervical carcinoma and ovarian cancers in most developing nations including Nigeria. Estrogen has been described as a promoter of endometrial carcinogenesis. Objectives: The aim...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/11910
042 |a dc 
720 |a Odetola, S. S.  |e author 
720 |a Ajani, M. A.  |e author 
720 |a Iyapo, O.  |e author 
720 |a Salami, A. A.  |e author 
720 |a Okolo, C. A.  |e author 
260 |c 2022 
520 |a Background: Endometrial carcinoma is the commonest genital tract malignancy in most developed nations, but it lags behind cervical carcinoma and ovarian cancers in most developing nations including Nigeria. Estrogen has been described as a promoter of endometrial carcinogenesis. Objectives: The aim of this study was to demonstrate the frequency of estrogen receptor (ER) and progesterone receptor (PR) expressions of endometrial carcinoma and to correlate it with tumour grade. Materials and Methods: Cases of endometrial carcinoma diagnosed in the Department of Pathology over a 10-year period were reviewed retrospectively. The paraffin-embedded blocks were retrieved, and immunohistochemistry for ER and PR was performed on them. Haematoxylin and eosin (H&E) slides were reviewed, and tumours were graded by three independent pathologists. Data were analysed using SPSS version 22. The level of significance was set at P ≤ 0.05. Results: There were 44 cases of endometrial carcinoma. ER and PR were positive in 29.5% and 18.2% of endometrial carcinoma, respectively. There was no significant association between ER (P = 0.361) and PR (P = 0.204) expressions and histological grade of the tumour. The most common histological grade was grade 3 with 70% of cases (36 cases), whereas 13 cases (26%) were grade 2 and only 2 cases (4%) were grade 1. Conclusion: The positive expressions of ER and PR in endometrial carcinoma suggest that steroid receptor studies may be of potential benefit in the management of some patients with endometrial carcinoma. Future studies employing larger sample size are therefore recommended. 
024 8 |a 2276-6944 
024 8 |a ui_art_odetola_hormonal_2022 
024 8 |a Journal of the West African College of Surgeons 10(2), pp. 1-4 
024 8 |a https://repository.ui.edu.ng/handle/123456789/11910 
653 |a Endometrial carcinoma 
653 |a Estrogen receptor 
653 |a Hormone receptors 
653 |a Progesterone receptor 
245 0 0 |a Hormonal receptor expression in endometrial carcinoma: a retrospective immunohistochemical study in a Nigerian tertiary hospital